Aperna F, Alsugair AK, Fathima S, Tefferi A, Gangat N. Incidental changes in hemoglobin levels in patients with myelofibrosis receiving treatment with sodium-glucose co-transporter-2 inhibitors. haematol [Internet]. 2025Apr.1 [cited 2025Dec.5];110(4):1034-7. Available from: https://haematologica.org/article/view/11855